IMR Press / EJGO / Volume 30 / Issue 3 / pii/2009068

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research

Elevated blood active ghrelin and normal total ghrelin and obestatin concentrations in uterine leiomyoma

Show Less
1 Department of Perinatology and Gynaecology, Poznan University of Medical Sciences, Poznan (Poland)
2 Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan (Poland)
3 Department of Oncology, Poznan University of Medical Sciences, Poznan (Poland)
Eur. J. Gynaecol. Oncol. 2009, 30(3), 281–284;
Published: 10 June 2009

Ghrelin and obestatin originate from the same peptide precursor, preproghrelin. Both peptides are secreted in the blood. We inves-tigated serum active and total ghrelin and obestatin concentrations in women with uterine myomatosis. Serum concentrations of active ghrelin in uterine leiomyoma were significantly higher compared to women in the control group (86 ± 3 vs 56 ± 9 pg/mL, respectively; p < 0.02). On the other hand, serum concentrations of total ghrelin and obestatin in uterine leiomyoma did not differ from those in the control group. In the control group the ratio of active to total ghrelin concentrations amounted to 0.62, while in women with uterine myoma it was 0.95, pointing to a prevalence of the active form of ghrelin in women with uterine myoma. Also the ratio of active ghrelin concentration to obestatin concentration was higher in the latter group while the ratio of total circulating ghrelin to obestatin concentrations was similar in the two groups. The data may suggest a role of active ghrelin in the development of a myoma. Moreover, the results indicate that increased blood ratios of active to total ghrelin and to obestatin concentrations are not specific for cachexia.

Uterine leiomyoma
Back to top